Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Sydnexis
45 Marine View Ave #295
Del Mar, CA 92014
Phone: 858-925-6172
https://sydnexis.com/

Sydnexis is a San Diego based clinical stage pharmaceutical company currently in the middle of a pivotal Phase 3 study, focused on the development of a novel proprietary formulation of low dose atropine for the treatment of myopia.

Key Contact
Name
Kenneth J. Widder, MD
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
08/10/21 $45,000,000 Series B Blue Stem Capital
Longitude Capital
Medicxi
RA Capital Management
SC Master Fund
Visionary Ventures Fund
undisclosed